SCHEMBL7203205

SCHEMBL7203205

Oc1ccc(C2=NNC(c3cccs3)C2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.58
KDM4E B2RXH2 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
BCHE P06276 3/20 0.50
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
MAOB P27338 4/20 0.40
MAOA P21397 1/20 0.39
LMNA P02545 1/20 0.39
CXCL12 P48061 1/20 0.38
ACHE P22303 1/20 0.37
GAA P10253 3/20 0.36
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7203726 0.87 MEN1 (0.53) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7206032 0.86 MAPT (0.52) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL27760026 0.86 MEN1 (0.52) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7200601 0.86 MEN1 (0.65) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7206304 0.86 MEN1 (0.52) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7203657 0.86 KDM4E (0.52) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL8082283 0.85 MAPT (0.58) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7200422 0.84 MAPT (0.51) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7199122 0.84 MEN1 (0.51) MAPTKDM4EMEN1KMT2ABCHE
SCHEMBL7200293 0.83 MEN1 (0.50) MAPTKDM4EMEN1KMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605730-B2 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula NIHON BAYER AGROCHEM K.K. (JP) 2003-08-12 US disclosed
US-20030028034-A1 Nematicidal pyrazoles WADA KATSUAKI (JP) 2003-02-06 US disclosed
US-6310049-B1 3-(2-THIENYL),5-(SUBSTITUTED PHENYL)-1H-PYRAZOLES AND 3-(SUBSTITUTED PHENYL),5-(2-THIENYL)-1H-PYRAZOLES OF GIVEN FORMULA; ANTHELMINTICS NIHON BAYER AGROCHEM K.K. (JP) 2001-10-30 US disclosed
EP-1104418-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2001-06-06 EP disclosed
WO-2000009500-A2 NEMATICIDAL PYRAZOLES NIHON BAYER AGROCHEM K.K. (JP) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030028034-A1 Nematicidal pyrazoles CBR3, CBR1, CCR4 MAPT 4683/4885KDM4E 2628/4885MEN1 4820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.